Fang Liang Zhang
Chairman chez LEGEND BIOTECH CORPORATION
Fortune : 346 M $ au 31/03/2024
Profil
Fang Liang Zhang is the founder of GenScript Corp.
(founded in 2002) and Genscript Biotech Corp.
(founded in 2002).
He currently holds the position of Chairman at Legend Biotech Corp.
and Director at GenScript (Hong Kong) Ltd.
He is also an Executive Director at Genscript Biotech Corp.
and holds director positions at Nanjing Jinsirui Biotechnology Co., Ltd., Jinsikang Technology (Nanjing) Co., Ltd., Nanjing Bestzyme Bioengineering Co., Ltd., Hubei Bestzyme Biotechnology Co. Ltd., Shanghai Jingrui Biotechnology Co. Ltd., Bestzyme Biotech Corp., Bestzyme Biotech Hk Ltd., Bestzyme Biotech Ltd., Bestzyme Biotech USA, Inc., Nanjing Legend Biotechnology Co., Ltd., Legend Biotech HK Ltd., Legend Biotech Ltd., Genscript Biotech Ltd., GenScript International Ltd., and GenScript USA, Inc. His former positions include Chairman & Chief Executive Officer at Nanjingjinsirui Science & Technology Biology Corp., Director at Legend Biotech Corp.
(2020), and Principal Scientist at Schering-Plough Holdings Ltd.
(2002).
Dr. Zhang obtained a doctorate degree from Duke University in 1995, a graduate degree from Nanjing University in 1987, and an undergraduate degree from Chengdu University of Technology in 1984.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/03/2024 | 170 753 326 ( 8,04% ) | 316 M $ | 31/03/2024 | |
LEGEND BIOTECH CORP.
0,37% | 31/12/2022 | 1 067 386 ( 0,37% ) | 30 M $ | 31/03/2024 |
Postes actifs de Fang Liang Zhang
| Sociétés | Poste | Début |
|---|---|---|
| GENSCRIPT BIOTECH CORPORATION | Director/Board Member | 02/05/2022 |
| LEGEND BIOTECH CORPORATION | Chairman | 02/08/2022 |
| Bestzyme Biotech Hk Ltd. | Director/Board Member | - |
GenScript USA, Inc.
 GenScript USA, Inc. Medical SpecialtiesHealth Technology GenScript USA, Inc. engages in the provision of life science research services. The company is headquartered in United States. | Director/Board Member | - |
| GenScript International Ltd. | Director/Board Member | - |
GenScript (Hong Kong) Ltd.
 GenScript (Hong Kong) Ltd. Medical/Nursing ServicesHealth Services Part of Genscript Biotech Corp., GenScript (Hong Kong) Ltd. provides diagnostic services for medical professionals. The private company is based in Hong Kong, Hong Kong. | Director/Board Member | - |
| Genscript Biotech Ltd. | Director/Board Member | 02/05/2022 |
| Legend Biotech Ltd. | Director/Board Member | - |
| Legend Biotech HK Ltd. | Director/Board Member | - |
| ░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Fang Liang Zhang
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Formation de Fang Liang Zhang
| Duke University | Doctorate Degree |
| Nanjing University | Graduate Degree |
| Chengdu University of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GENSCRIPT BIOTECH CORPORATION | Health Technology |
| LEGEND BIOTECH CORPORATION | Health Technology |
| Entreprise privées | 19 |
|---|---|
Schering-Plough Holdings Ltd.
 Schering-Plough Holdings Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Holdings Ltd. develops and manufactures pharmaceutical products. It offers sterilization tablets, cotton buds, and animal & veterinary health products. The company is headquartered in Welwyn Garden City, UK. | Health Technology |
GenScript Corp.
 GenScript Corp. BiotechnologyHealth Technology GenScript Corp. provides biological research and drug discovery services to pharmaceutical companies. Its products include antibodies, recombinant proteins, protein isolation and analysis, molecular biology reagents, peptides, and cell lines. It offers life sciences research services and preclinical drug development services. The company was founded by Ye Wang, Fang Liang Zhang, and Lu Quan Wang in 2002 and is headquartered in Piscataway, NJ. | Health Technology |
Nanjingjinsirui Science & Technology Biology Corp.
 Nanjingjinsirui Science & Technology Biology Corp. BiotechnologyHealth Technology Nanjing Genscript Co., Ltd. provides biological and pharmaceutical research services. It offers gene, peptide, protein production and purification, and antibody outsourcing services. The company was founded in 2004 and is headquartered in Nanjing, China. | Health Technology |
GenScript (Hong Kong) Ltd.
GenScript (Hong Kong) Ltd. Medical/Nursing ServicesHealth Services Part of Genscript Biotech Corp., GenScript (Hong Kong) Ltd. provides diagnostic services for medical professionals. The private company is based in Hong Kong, Hong Kong. | Health Services |
| Nanjing Jinsirui Biotechnology Co., Ltd. | |
| Jinsikang Technology (Nanjing) Co., Ltd. | |
Nanjing Bestzyme Bioengineering Co., Ltd.
 Nanjing Bestzyme Bioengineering Co., Ltd. BiotechnologyHealth Technology Nanjing Bestzyme Bioengineering Co., Ltd. provides biological research and drug discovery services to pharmaceutical companies. The joint venture company is based in Nanjing, China. and has subsidiaries in China. | Health Technology |
| Hubei Bestzyme Biotechnology Co. Ltd. | |
| Shanghai Jingrui Biotechnology Co. Ltd. | |
| Bestzyme Biotech Corp. | |
| Bestzyme Biotech Hk Ltd. | |
| Bestzyme Biotech Ltd. | |
| Bestzyme Biotech USA, Inc. | |
Nanjing Legend Biotechnology Co., Ltd.
 Nanjing Legend Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Nanjing Legend Biotechnology Co., Ltd. is a commercial-stage biotechnology company based in Nanjing, CN. Nanjing Legend Biotechnology Co. is exploring several innovative and evolving technologies to treat hematologic malignancies and solid tumors, including autologous chimeric antigen receptor T-cell therapy, allogeneic non-gene-editing CAR-T, natural killer cells, and CAR-?? T cells. The Chinese company is fiercely pursuing and delivering therapies to transform the world of oncology and medicine. The private company is currently developing and commercializing novel therapies to help strengthen patients' immune systems and fight disease. The company's pipeline is made up of novel therapies and innovative technologies in personalized medicine, and they are devoted to exploring the potential of cell therapies to treat diseases that are considered intractable and incurable, such as hematological malignancies and solid tumors. | Commercial Services |
| Legend Biotech HK Ltd. | |
| Legend Biotech Ltd. | |
| Genscript Biotech Ltd. | |
| GenScript International Ltd. | |
GenScript USA, Inc.
GenScript USA, Inc. Medical SpecialtiesHealth Technology GenScript USA, Inc. engages in the provision of life science research services. The company is headquartered in United States. | Health Technology |
